Insiders · Profile

Holsinger Leslie

Executive Vice President at Quince Therapeutics. Filing since 14 Dec 2020. CIK 0001770821

Company

Date

Role

Action

Amount

Of holding

14 Dec 2020

Executive Vice President

Sold, plan not stated

40,000

$1.23M

95.7%

1 decision on file.